BioCentury
ARTICLE | Financial News

Crucell to sell IPO

September 27, 2000 7:00 AM UTC

Crucell, which was formed through the merger of IntroGene BV and U-BiSys, announced plans to float an IPO on both the Amsterdam stock exchange and NASDAQ. Goldman Sachs will serve as global coordinato...